Dinodnavirus
Dinodnavirus is a genus of viruses in the family Parvoviridae. Dinodnaviruses are known to infect dinoflagellates, a group of single-celled organisms found in marine and freshwater environments. The name "Dinodnavirus" is derived from "dinoflagellate DNA virus".
Taxonomy[edit]
The genus Dinodnavirus is part of the subfamily Densovirinae, within the family Parvoviridae. The Parvoviridae family is composed of small, non-enveloped viruses with a linear, single-stranded DNA genome. The family is divided into two subfamilies: the Densovirinae, which infect invertebrates, and the Parvovirinae, which infect vertebrates.
Structure[edit]
Dinodnaviruses are non-enveloped viruses with icosahedral symmetry. The capsid is composed of 60 capsomers and is approximately 18-26 nm in diameter. The genome is linear, non-segmented, and around 4-6 kilobases in length.
Life Cycle[edit]
The life cycle of Dinodnavirus involves attachment to the host cell, penetration into the cell, uncoating of the virus, replication of the viral genome, assembly of new virus particles, and release of the new viruses from the host cell. The virus attaches to the host cell using a viral attachment protein, which binds to a receptor on the host cell surface. The virus then enters the cell through receptor-mediated endocytosis.
Pathogenicity[edit]
Dinodnaviruses are known to cause disease in dinoflagellates, leading to population declines in some species. The impact of these viruses on dinoflagellate populations can have significant effects on marine and freshwater ecosystems, as dinoflagellates play a crucial role in these environments.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian